[1] 蔡洁娜,胡志明,张犁,等. 口服脂肪酶对高脂性模型大鼠脂代谢和脂肪肝的影响[J]. 广东医学, 2014,35(7):989-992. [2] 吴人照,吴焕淦,寿张根,等. 生物信息反馈红外治疗仪对高血脂大鼠降脂作用的实验研究[J]. 世界中医药, 2016,11(12):2533-2538. [3] 郝维佳,李静宜,蒋辉,等. 纯化成分高脂/高糖饲料的优势及国内应用现状[J]. 卫生研究,2017,46(1):143-147. [4] 徐勇勇,孙振球.医学统计学[M]. 4版. 北京:人民卫生出版社, 2015:571-574. [5] Lu Y, Li H, Shen S W, et al. Swimming exercise increases serum irisin level and reduces body fat mass in high-fat-diet fed Wistar rats[J]. Lipids Health Dis, 2016, 15:93-100. [6] 何明,涂长春,黄起壬,等. Lee's指数用于评价成年大鼠肥胖程度的探讨[J]. 中国临床药理学与治疗学杂志, 1997,2(3):177-179. [7] 董乃相,张书义,梁玉磊,等. 针刺对不同性别单纯性肥胖大鼠Lee's指数与Leptin含量的影响[J]. 中医学报, 2015,30(6):846-848. [8] Van der Heijden R A, Sheedfar F, Morrison M C, et al. High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice[J]. Aging (Albany NY), 2015, 7(4):256-268. [9] 曹艳丽,谷剑秋,王涤非,等. 肥胖者脂肪组织中TNF-α表达与脂肪细胞大小的相关性分析[J]. 中国组织化学与细胞化学杂志,2013,22(4):282-285. [10] Aoki S, Iwai A, Kawata K, et al. Oral administration of the aureobasidium pullulans-derived β-glucan effectively prevents the development of high fat diet-induced fatty liver in mice[J]. Sci Rep, 2015, 5:10457-10466. [11] 常露,赵珍,朱振东,等. 两种高脂饲料分段喂养对大鼠体重和血脂的影响[J]. 昆明医科大学学报, 2015,36(8):19-22. [12] Sung Y Y, Kim D S, Choi G, et al. Dohaekseunggi-tang extract inhibits obesity, hyperlipidemia, and hypertension in high-fat diet-induced obese mice[J]. BMC Complement Altern Med, 2014, 14:372-380. [13] Han J M, Lee J S, Kim H G, et al. Synergistic effects of Artemisia iwayomogi and Curcuma longa radix on high-fat diet-induced hyperlipidemia in a mouse model[J]. J Ethnopharmacol, 2015, 173:217-224. [14] Lee H S, Nam Y, Chung Y H, et al. Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice[J]. Life Sci, 2014, 118(1):7-14. [15] Al-Noory A S, Amreen A N, Hymoor S. Antihyperlipidemic effects of ginger extracts in alloxan-induced diabetes and propylthiouracil-induced hypothyroidism in (rats)[J]. Pharmacognosy Res, 2013, 5(3):157-161. [16] Pandrc M S, Ristic A, Kostovski V, et al. The effect of early substitution of subclinical hypothyroidism on biochemical blood parameters and the quality of life[J]. J Med Biochem, 2017, 36(2):127-136. [17] Hennessey J V, Espaillat R. Subclinical hypothyroidism:a historical view and shifting prevalence[J]. Int J Clin Pract, 2015, 69(7):771-782. [18] Pesic M M, Radojkovic D, Antic S, et al. Subclinical hypothyroidism:association with cardiovascular risk factors and components of metabolic syndrome[J]. Biotechnol Biotechnol Equip, 2015, 29(1):157-163. [19] Karabulut A, Dogan A, Tuzcu A K. Myocardial performance index for patients with overt and subclinical hypothyroidism[J]. Med Sci Monit, 2017, 23:2519-2526. [20] Ness G C, Pendleton L C, Li Y C, et al. Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats[J]. Biochem Biophys Res Commun, 1990, 172(3):1150-1156. [21] Pearce E N. Hypothyroidism and dyslipidemia:modern concepts and approaches[J]. Curr Cardiol Rep, 2004, 6(6):451-456. [22] Thompson G R, Soutar A K, Spengel F A, et al. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo[J]. Proc Natl Acad Sci U S A, 1981, 78(4):2591-2595. [23] Tian L, Song Y, Xing M, et al. A novel role for thyroid-stimulating hormone:up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase expression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosinemonophosphate-responsive element binding protein pathway[J]. Hepatology,2010, 52(4):1401-1409. [24] Zhang T, Zhou L, Li C C, et al. TSH increases synthesis of hepatic ATP-binding cassette subfamily A member 1 in hypercholesterolemia[J]. Biochem Biophys Res Commun, 2016, 476(2):75-81. [25] Tan K C, Shiu S W, Kung A W. Plasma cholesteryl ester transfer protein activity in hyper-and hypothyroidism[J]. J Clin Endocrinol Metab, 1998, 83(1):140-143. [26] Lam K S, Chan M K, Yeung R T. High-density lipoprotein cholesterol, hepatic lipase and lipoprotein lipase activities in thyroid dysfunction-effects of treatment[J]. Q J Med, 1986, 59(229):513-521. [27] Johansson L, Rudling M, Scanlan T S, et al. Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice[J]. Proc Natl Acad Sci U S A, 2005, 102(29):10297-10302. |